• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/13/24 8:00:00 PM ET
    $AXON
    $ILMN
    $MRNA
    $MSTR
    Ordnance And Accessories
    Industrials
    Medical Specialities
    Health Care
    Get the next $AXON alert in real time by email

    NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 23, 2024.

    The following three companies will be added to the Index: Palantir Technologies Inc. (NASDAQ:PLTR), MicroStrategy Incorporated (NASDAQ:MSTR), and Axon Enterprise, Inc. (NASDAQ:AXON).

    The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies1 listed on The Nasdaq Stock Market® and dates to January 1985 – nearly 40 years ago –when it was launched along with the Nasdaq Financial-100™ Index, which is comprised of 100 of the largest financial stocks on Nasdaq® These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (NASDAQ:QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following three companies will be removed from the Index: Illumina, Inc. (NASDAQ:ILMN), Super Micro Computer, Inc. (NASDAQ:SMCI), and Moderna, Inc. (NASDAQ:MRNA).

    Information

    For information about the three companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

    Palantir Technologies Inc. – https://www.palantir.com/

    MicroStrategy Incorporated – https://www.microstrategy.com/

    Axon Enterprise, Inc. – https://www.axon.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    _______________

    1 As outlined in the Nasdaq-100 Index® Methodology

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X, or at www.nasdaq.com. 

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG - 

    Media Relations Contact Investor Relations Contact 
    Name: Jennifer Lawson

    Email: [email protected]

     Name: Index Client Services

    Email: [email protected]

     
        


    Primary Logo

    Get the next $AXON alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AXON
    $ILMN
    $MRNA
    $MSTR

    CompanyDatePrice TargetRatingAnalyst
    Strategy Inc
    $MSTR
    11/10/2025Sell → Neutral
    Monness Crespi & Hardt
    Super Micro Computer Inc.
    $SMCI
    11/6/2025Hold → Buy
    Argus
    Strategy Inc
    $MSTR
    10/15/2025$473.00Buy
    China Renaissance
    Axon Enterprise Inc.
    $AXON
    9/24/2025$893.00Overweight
    Piper Sandler
    Super Micro Computer Inc.
    $SMCI
    9/16/2025$46.00Mkt Perform
    Bernstein
    Illumina Inc.
    $ILMN
    8/12/2025$94.00Outperform → Neutral
    Daiwa Securities
    Axon Enterprise Inc.
    $AXON
    8/5/2025$900.00Hold → Buy
    Craig Hallum
    Palantir Technologies Inc.
    $PLTR
    8/5/2025$160.00Sell → Hold
    Deutsche Bank
    More analyst ratings

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Strategy Inc upgraded by Monness Crespi & Hardt

    Monness Crespi & Hardt upgraded Strategy Inc from Sell to Neutral

    11/10/25 8:37:33 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    Super Micro Computer upgraded by Argus

    Argus upgraded Super Micro Computer from Hold to Buy

    11/6/25 7:30:56 AM ET
    $SMCI
    Computer Manufacturing
    Technology

    China Renaissance initiated coverage on Strategy Inc with a new price target

    China Renaissance initiated coverage of Strategy Inc with a rating of Buy and set a new price target of $473.00

    10/15/25 8:32:19 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nasdaq Executives to Present at Upcoming Investor Conferences

    NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) will be presenting at the following conferences with webcasts available at Nasdaq's Investor Relations website: ir.nasdaq.com/events.cfm. Who:Sarah Youngwood, Executive Vice President and CFO, NasdaqWhat:J.P. Morgan 2025 Ultimate Services Investor ConferenceWhen:Wednesday, November 18, 20252:00 PM ET Who:Sarah Youngwood, Executive Vice President and CFO, NasdaqWhat:2025 RBC Capital Markets Global Technology, Internet, Media & Telecommunications ConferenceWhen:Tuesday, November 19, 202510:40AM ET  Who:Sarah Youngwood, Executive Vice President and CFO, NasdaqWhat:UBS Global Technology and AI ConferenceWhen:Tuesday, December 2,

    11/13/25 4:05:00 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

    Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood pressure and cholesterol Results demonstrate the advantages of WGS over WES and genotyping arrays for assessing genetic risk and identifying drug target candidates. SAN DIEGO, Nov. 12, 2025 /PRNewswire/ -- A study published today in Nature, authored by Illumina, Inc. (NASDAQ:ILMN) scientists and by collaborators from The University of Queensland demonstrates the importance of whole-genome sequencing (WGS) to more fully capture the genetics underlying complex human traits and diseases. Across all

    11/12/25 12:00:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Nasdaq Celebrates the Permian Basin by Ringing the Nasdaq Stock Market Closing Bell in Midland, Texas

    MIDLAND, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today joins Daniel Energy Partners and leaders across the oil and gas industry at the 8th Annual Permian Basin BBQ Cook-Off, powered by Upright Digital, in Midland, Texas, to celebrate the region's leadership role in powering the world's economy. The company will ring the Market Closing Bell from the Permian Basin, underscoring Nasdaq's long-standing partnership with the state and its commitment to supporting Texas's continued leadership in innovation and growth. The event at the Permian Basin brings together executives and innovators from across the energy sector to connect, celebrate, and collaborate on continuing to

    11/12/25 8:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $AXON
    $ILMN
    $MRNA
    $MSTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Leadership Updates

    Live Leadership Updates

    View All

    Surf Air Mobility Appoints Shawn Pelsinger to Board of Directors

    Mr. Pelsinger was formerly the Global Head of Corporate Development & Senior Counsel of Palantir Technologies. Surf Air Mobility Inc. (NYSE:SRFM) ("the Company", "Surf Air Mobility"), a leading regional air mobility platform, announced today the appointment of Shawn Pelsinger to the Company's Board of Directors, effective October 8, 2025. Mr. Pelsinger is currently Chief Legal Officer and Chief Administrative Officer of Acrisure, a global fintech provider of solutions across insurance, reinsurance, payroll, benefits, cybersecurity, and real estate services. Prior to joining Acrisure, Mr. Pelsinger was the Global Head of Corporate Development & Senior Counsel of Palantir Technologies (

    10/8/25 6:30:00 AM ET
    $PLTR
    $SRFM
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

    Brian McKernan joins as CEO to further advance Predicta's clinical impact, including its non-invasive diagnostic for Multiple Myeloma Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubscribed $23.4 million Series A led by Engine Ventures. Additional participating investors include Illumina Ventures, Lightchain Capital, Mass General Brigham Ventures, ACS BrightEdge, Binney Street Capital of Dana-Farber Cancer Institute and Myeloma Solutions Fund. The capital will be used to expand Predicta's team and CLIA-approved lab infrastructure, and advance commercialization of the company's first

    10/1/25 9:00:00 AM ET
    $ILMN
    Medical Specialities
    Health Care

    Lambda Appoints Heather Planishek to Board of Directors as Audit Chair

    Industry veteran brings deep financial and operational expertise from Tines and Palantir Lambda, the Superintelligence Cloud, today announced the appointment of Heather Planishek to its Board of Directors, where she will serve as Audit Chair. Planishek brings extensive experience scaling high-growth technology companies, currently serving as Chief Operating and Financial Officer at Tines, the intelligent workflow platform. She previously served as Chief Accounting Officer at Palantir Technologies Inc. (NASDAQ: PLTR), where she guided the company through a period of significant growth and its transition to the public markets. This press release features multimedia. View the full release h

    9/25/25 8:00:00 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Financials

    Live finance-specific insights

    View All

    Supermicro Announces First Quarter Fiscal Year 2026 Financial Results

    Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced unaudited financial results for its first quarter of fiscal year 2026 ended September 30, 2025. First Quarter Fiscal Year 2026 Highlights Net sales of $5.0 billion versus $5.8 billion in Q4'25 and $5.9 billion in Q1'25 Gross margin of 9.3% versus 9.5% in Q4'25 and 13.1% in Q1'25 Net income of $168 million versus $195 million in Q4'25 and $424 million in Q1'25 Diluted net income per common share of $0.26 versus $0.31 in Q4'25 and $0.67 in Q1'25 Non-GAAP diluted net income per common share of $0.35 versus $0.73 in Q1'25 C

    11/4/25 4:05:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    Axon reports Q3 2025 revenue of $711 million, up 31% year over year

    SCOTTSDALE, Ariz., Nov. 4, 2025 /PRNewswire/ -- Software & Services revenue grows 41% to $305 millionAnnual recurring revenue grows 41% to $1.3 billionNet loss was $2 million, with non-GAAP net income of $98 million and Adjusted EBITDA of $177 millionRaises full year revenue outlook to approximately $2.74 billion, 31% annual growth, up from $2.65 billion to $2.73 billion previously.Fellow shareholders, Axon delivered another record quarter, with revenue growing 31% year over year to $711 million — our seventh consecutive quarter of growth above 30% — and GAAP net loss margin o

    11/4/25 4:01:00 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

    Revenue of $1.08 billion for Q3 2025, flat compared to Q3 2024 on both a reported and constant currency basisGAAP operating margin of 21.0% and non-GAAP operating margin of 24.5% for Q3 2025GAAP diluted EPS of $0.98 and non-GAAP diluted EPS of $1.34 for Q3 2025Cash provided by operations of $284 million and free cash flow of $253 million for Q3 2025Repurchased 1.2 million shares of our common stock for $120 million at an average price of $97.10 per shareFor fiscal year 2025, we now expect:Total company constant currency revenue decline in the range of (1.5%) to (0.5%), up from (2.5%) to (1.5%)Revenue growth outside of China in the range of 0.5% - 1.5% on a constant currency basis, with no ch

    10/30/25 4:05:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO & CFO Bagley Brittany sold $1,525,000 worth of shares (2,500 units at $610.00), decreasing direct ownership by 3% to 91,092 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    11/13/25 5:04:45 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Chief Legal Officer Davies Scott M returned $39,661 worth of shares to the company (323 units at $122.79), decreasing direct ownership by 2% to 18,210 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    11/13/25 4:49:15 PM ET
    $ILMN
    Medical Specialities
    Health Care

    SVP, Chief Accounting Officer Cheung Kenneth converted options into 1,250 shares and covered exercise/tax liability with 635 shares, increasing direct ownership by 1% to 56,472 units (SEC Form 4)

    4 - Super Micro Computer, Inc. (0001375365) (Issuer)

    11/12/25 5:07:18 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    SEC Filings

    View All

    Moderna Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Moderna, Inc. (0001682852) (Filer)

    11/13/25 4:19:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC TO-I filed by Moderna Inc.

    SC TO-I - Moderna, Inc. (0001682852) (Subject)

    11/13/25 8:21:12 AM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC TO-C filed by Moderna Inc.

    SC TO-C - Moderna, Inc. (0001682852) (Subject)

    11/12/25 5:21:39 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gottlieb Scott bought $61,065 worth of shares (500 units at $122.13), increasing direct ownership by 4% to 12,523 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    11/5/25 4:05:20 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Director Partovi Hadi bought $1,004,920 worth of shares (1,358 units at $740.00), increasing direct ownership by 0.57% to 237,938 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    8/15/25 4:36:59 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Director Briger Peter L Jr bought $19,800,000 worth of Series A Perpetual Stretch Preferred Stock (220,000 units at $90.00) (SEC Form 4)

    4 - MICROSTRATEGY Inc (0001050446) (Issuer)

    7/29/25 6:20:52 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by MicroStrategy Incorporated

    SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

    11/14/24 6:24:12 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology